Skyhawk racks up more support for Huntington’s drug

Data ReadoutpositivePositive

AI Analysis

Summary

Skyhawk released 15-month data from a small study of its RNA-splicing therapy for Huntington's disease, generating additional support for the program.

Clinical Trial Data

Outcome Details

15-month data from small study of RNA-splicing therapy

Importance:5/10

Sentiment:

0.60

Huntington's diseaseRNA-splicingclinical dataFidelity-backed

Read the original article

Published by BioPharma Dive on September 16, 2026 1:05 PM

Read Original